文献速递老年综合评估衰弱、肌少症与跌倒老年慢病共病管理

心力衰竭患者的多病共存与功能受限:前瞻性社区研究

Multimorbidity and Functional Limitation in Individuals with Heart Failure: A Prospective Community Study.
PubMed 文献 · J Am Geriatr Soc · 2018-03-30

该前瞻性社区队列纳入2692例首次诊断心衰的居民(平均74岁,54%男性),评估多病共存与功能受限对医疗使用和死亡的影响。同时存在多病共存和功能受限者死亡及各类医疗使用风险最高(死亡HR=4.92)。仅功能受限者住院和急诊风险与仅多病共存者相近,提示管理心衰时需同时考虑两者。

要点

  • 同时有多病共存和功能受限的心衰患者死亡风险最高(HR=4.92)。
  • 仅功能受限者死亡、急诊和住院风险也升高,但门诊就诊未见升高。
  • 仅多病共存者急诊和住院风险与仅功能受限者相近,门诊就诊更多。

核心结论

  • 同时存在多病共存和功能受限的心衰患者死亡和医疗使用风险最高。
  • 仅功能受限者住院和急诊风险与仅多病共存者相近,管理心衰时需同时考虑两者。

研究设计与样本

  • 参与者平均年龄74岁,54%为男性。
  • 功能受限用8项日常生活活动能力Likert量表评估,总分大于8分定义为功能受限;多病共存定义为2种及以上非心脏共病。

主要发现

  • 调整后,同时有多病共存和功能受限者较两者均无者死亡风险HR=4.92(95%CI=3.03-8.00),急诊就诊HR=3.67(95%CI=2.94-4.59),住院HR=3.66(95%CI=2.85-4.70),门诊就诊HR=1.73(95%CI=1.52-1.96)。
  • 仅功能受限者较两者均无者死亡风险HR=4.84(95%CI=2.78-8.43),急诊就诊HR=2.35(95%CI=1.75-3.16),住院HR=2.10(95%CI=1.52-2.88),门诊就诊风险未见升高。
  • 仅多病共存者急诊和住院风险与仅功能受限者相近,但门诊就诊风险更高(HR=1.50,95%CI=1.34-1.67)。

关键数值与推荐

  • 功能受限:8项日常生活活动能力总分大于8分(量表1分=毫无困难,5分=无法完成)。
  • 多病共存:存在2种及以上非心脏共病。

临床怎么用

  • 对心衰患者应同时评估多病共存和功能受限,两者并存者死亡和医疗使用风险最高。
  • 仅功能受限的心衰患者急诊和住院风险与仅多病共存者相近,不应只关注共病数量而忽略功能状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize the individual and combined effects of multimorbidity and functional limitation on healthcare use and mortality in a large, community cohort of individuals with heart failure (HF). DESIGN: Prospective cohort study. SETTING: Eleven southeastern Minnesota counties. PARTICIPANTS: Individuals (mean age 74, 54% male) with a first-ever HF code (International Classification of Diseases, Ninth Revision code 428 or Tenth Revision code I50) between January 1, 2013 and March 31, 2016 (N=2,692). MEASUREMENTS: Eight activities of daily living measured using a survey on a Likert scale (1=without any difficulty, 5=unable to do; median=8). Participants with a score greater than 8 were categorized as having functional limitation. Multimorbidity was defined as having 2 or more noncardiac comorbidities. RESULTS: Twenty-five percent of participants had neither multimorbidity nor functional limitation, 35% had multimorbidity, 9% had functional limitation, and 31% had both. After adjustment, participants with multimorbidity and functional limitation had greater risks of all outcomes (death: hazard ratio (HR)=4.92, 95% confidence interval (CI)=3.03-8.00; emergency department (ED) visit: HR=3.67, 95% CI=2.94-4.59; hospitalization: HR=3.66, 95% CI=2.85-4.70; outpatient visit: HR=1.73, 95% CI=1.52-1.96) than those with neither. Participants with functional limitation alone had greater risks of death (HR=4.84, 95% CI=2.78-8.43), ED visits (HR=2.35, 95% CI=1.75-3.16), and hospitalizations (HR=2.10, 95% CI=1.52-2.88) but not outpatient visits. Those with multimorbidity alone had similar risks of ED visits and hospitalizations as those with functional limitation alone but were more likely to have outpatient visits (HR=1.50, 95% CI=1.34-1.67). CONCLUSION: Individuals with both multimorbidity and functional limitation have the highest risk of death and healthcare use. Individuals with only functional limitation have similar rates of hospitalizations and ED visits as those with only multimorbidity, underscoring the need to consider both when managing individuals with HF.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Manemann SM, Chamberlain AM, Roger VL, et al. Multimorbidity and Functional Limitation in Individuals with Heart Failure: A Prospective Community Study. J Am Geriatr Soc. 2018. PMID: 29603724. doi:10.1111/jgs.15336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。